Riskpilot← Back to searchSign inGet full accessREGENICS AS
ASActiveOrg 982277086Oslo Science Park Gaustadalléen 21, 0349 OsloTechnical testing and analysis · NACE 7120Est. 20005 employeeswww.regenics.no
Revenue 2024
NOK 2,3M
-28% vs 2023
EBITDA margin
-99.9%
-7578% vs 2023
Equity ratio
54.0%
Financial strength
Net profit 2024
NOK -6,3M
-73% vs 2023
| Revenue | NOK 2,3M | -28% |
| EBITDA | NOK -2,3M | -7578% |
| Net profit | NOK -6,3M | -73% |
| Total assets | NOK 43,6M | +40% |
| Equity | NOK 23,6M | +150% |
| Employees | 5 | — |
Legal name
REGENICS AS
Org number
982277086
Legal form
Aksjeselskap
NACE code
7120 · Technical testing and analysis
Founded
7. september 2000
Share capital
NOK 16 305 643
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Forskning, utvikling og salg av produkter og teknologier innenfor stamcelleforskning og dertil hørende virksomhet.
Address
Oslo Science Park Gaustadalléen 21, 0349 Oslo
Website
www.regenics.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 328 | 2 183 | 2 224 | 801 | 1 894 | 2 223 | 2 740 | 4 001 | 573 | 250 | 3 060 | 922 | 293 | 394 | 2 713 | 3 268 | 2 344 |
| Staff expenses | −1 865 | −1 350 | −1 643 | −1 270 | −1 522 | −1 668 | −478 | −0 | −0 | −0 | −211 | −226 | −100 | −108 | −906 | −1 009 | −2 540 |
| EBITDA | −418 | −718 | −640 | −2 253 | −1 147 | −1 260 | −326 | 4 024 | 507 | 155 | 1 841 | −458 | −860 | −1 546 | −272 | 31 | −2 340 |
| Depreciation & amort. | −7 | −58 | −91 | −117 | −65 | −110 | −77 | −22 | −40 | −3 | −1 | −0 | −0 | −0 | −3 273 | −3 642 | −3 943 |
| EBIT | −425 | −776 | −731 | −2 369 | −1 212 | −1 370 | −402 | 4 001 | 467 | 151 | 1 840 | −458 | −860 | −1 546 | −3 545 | −3 610 | −6 283 |
| Net financials | 67 | 30 | 5 | 5 | −133 | −157 | −133 | −168 | −115 | −105 | −120 | −129 | −66 | −118 | −191 | −24 | −9 |
| Profit before tax | −357 | −746 | −726 | −2 364 | −1 345 | −1 527 | −535 | 3 833 | 352 | 47 | 1 720 | −587 | −926 | −1 664 | −3 735 | −3 635 | −6 292 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −357 | −746 | −726 | −2 364 | −1 345 | −1 527 | −535 | 3 833 | 352 | 47 | 1 720 | −587 | −926 | −1 664 | −3 735 | −3 635 | −6 292 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 478 | 2 513 | 2 658 | 2 663 | 2 305 | 2 032 | 1 503 | 7 247 | 13 781 | 22 219 | 25 986 | 28 119 | 30 778 | 35 276 | 34 348 | 31 138 | 43 595 |
| Equity | 1 590 | 1 344 | 1 590 | 1 188 | −157 | −1 389 | −1 924 | 2 909 | 2 532 | 5 803 | 8 628 | 8 041 | 7 615 | 8 048 | 11 655 | 9 423 | 23 551 |
| Long-term debt | 175 | 175 | 180 | 0 | 175 | 110 | 110 | 110 | 112 | 116 | 3 651 | 3 771 | 3 865 | 4 378 | 331 | 279 | 93 |
| Short-term debt | 714 | 995 | 888 | 1 299 | 2 287 | 3 312 | 3 317 | 4 228 | 3 992 | 5 710 | 1 108 | 628 | 675 | 2 503 | 1 307 | 1 657 | 1 388 |
| Total debt | 889 | 1 170 | 1 068 | 1 474 | 2 462 | 3 421 | 3 427 | 4 338 | 4 105 | 5 826 | 4 759 | 4 399 | 4 539 | 6 880 | 1 638 | 1 936 | 1 481 |
EBITDA margin
-99.9%
This company
15.8%
Market median
-732% vs market
20082024
Equity ratio
54.0%
This company
38.2%
Market median
+41% vs market
20082024
Return on equity
-26.7%
This company
18.4%
Market median
-245% vs market
20082024
Net profit margin
-268.5%
This company
8.1%
Market median
-3415% vs market
20082024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20082024
Debt / equity
0.85×
This company
0.62×
Market median
+37% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JG Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
KM Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
HL Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
KR Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2025 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Life Capitol As | Company | 26.6% | 26.6% | 2024 |
Heldrup As | Company | 20.3% | 20.3% | 2024 |
Íslandsbanki Hf. | Company | 20.0% | 20.0% | 2024 |
| Individual | 8.2% | 8.2% | 2022 | |
Høgenipa As | Company | 6.1% | 6.1% | 2024 |
Cornucopia As | Company | 5.0% | 5.0% | 2024 |
Intento As | Company | 4.4% | 4.4% | 2024 |
Capra Invest As | Company | 2.9% | 2.9% | 2024 |
Wlh Invest As | Company | 2.3% | 2.3% | 2024 |
| Individual | 2.0% | 2.0% | 2024 | |
| Individual | 1.5% | 1.5% | 2024 | |
Solvik Holding As | Company | 1.3% | 1.3% | 2024 |
Braktor Invest As | Company | 1.2% | 1.2% | 2024 |
| Individual | 1.1% | 1.1% | 2024 | |
| Individual | 1.1% | 1.1% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of REGENICS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jostein Grip | Chief Executive Officer | 0 companies |
| Karin Margaretha Gilljam | Chief Executive Officer | 0 companies |
| Henrik Lund | Chief Executive Officer | 0 companies |
| Karl Rasmus Kølleskov Bryn | Chief Executive Officer | 0 companies |
| Harald Nordal | Board of Directors | 0 companies |
| Wilhelm Loennecken Holst | Board of Directors | 0 companies |
| Tore Heldrup Rasmussen | Board of Directors | 0 companies |
| Brynjolfur Gisli Eyjolfsson | Chairman | 0 companies |
| Jan Alan Alfheim | Chairman | 0 companies |
| Beat Josef Moser | Board of Directors | 0 companies |